HIV-gp120- Fragment (308-331)
CAS No. 115416-08-5
HIV-gp120- Fragment (308-331)( ——— )
Catalog No. M41282 CAS No. 115416-08-5
HIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameHIV-gp120- Fragment (308-331)
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody.
-
DescriptionHIV gp120 308-331 is HIV antigen fragments, that conjugates with keyhole limpet hemocyanin (KLH) and generates specific anti-HIV antibody.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number115416-08-5
-
Formula Weight2640.11
-
Molecular FormulaC114H199N41O31
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Methyl ganoderate A
Methyl ganoderate A is a Farnesyl protein transferase (FPT) inhibitor with an IC50 value of 38 microM,which has potential anticancer effects.Methyl ganoderate A has inhibitory effect on fatty acid amide hydrolase (FAAH).
-
(Nle6)-Sarafotoxin C
(Nle6)-Sarafotoxin C
-
Chitinase, Serratia ...
Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).
Cart
sales@molnova.com